Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 May 2024.Powered by Capital Market - Live News

Net profit of Fredun Pharmaceuticals rose 21.97% to Rs 4.22 crore in the quarter ended December 2023 as against Rs 3.46 crore during the previous quarter ended December 2022. Sales rose 11.59% to Rs 86.65 crore in the quarter ended December 2023 as against Rs 77.65 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales86.6577.65 12 OPM %12.149.41 - PBDT6.755.36 26 PBT5.764.62 25 NP4.223.46 22 Powered by Capital Market - Live News

Fredun Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 18 January 2024.Powered by Capital Market - Live News

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 December 2023.Powered by Capital Market - Live News

Net profit of Fredun Pharmaceuticals rose 25.08% to Rs 3.94 crore in the quarter ended September 2023 as against Rs 3.15 crore during the previous quarter ended September 2022. Sales rose 18.36% to Rs 81.48 crore in the quarter ended September 2023 as against Rs 68.84 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales81.4868.84 18 OPM %11.799.86 - PBDT6.714.93 36 PBT5.774.21 37 NP3.943.15 25 Powered by Capital Market - Live News